Myocardial Revascularization
This graph shows the total number of publications written about "Myocardial Revascularization" by people in the URMC Research Network by year, and whether "Myocardial Revascularization" was a major or minor topic of these publication.
Below are the most recent publications written about "Myocardial Revascularization" by people in Profiles.
-
Swartz MF, Schiralli MP, Alfieris GM. Neonatal coronary revascularization: six-year follow-up period. Pediatr Cardiol. 2010 Oct; 31(7):1118.
-
Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008 Mar 11; 117(10):1283-91.
-
Fiscella K, Meldrum S, Barnett S. Hospital discharge against advice after myocardial infarction: deaths and readmissions. Am J Med. 2007 Dec; 120(12):1047-53.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006 May 2; 47(9):1811-7.
-
Gassler JP, Topol EJ. Reperfusion revisited: beyond TIMI 3 flow. Clin Cardiol. 1999 Aug; 22(8 Suppl):IV20-9.
-
Glance LG. Selective preoperative cardiac screening improves five-year survival in patients undergoing major vascular surgery: a cost-effectiveness analysis. J Cardiothorac Vasc Anesth. 1999 Jun; 13(3):265-71.
-
Narins CR, Miller DP, Califf RM, Topol EJ. The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. J Am Coll Cardiol. 1999 Mar; 33(3):647-53.
-
Phibbs B, Marcus F, Marriott HJ, Moss A, Spodick DH. Q-wave versus non-Q wave myocardial infarction: a meaningless distinction. J Am Coll Cardiol. 1999 Feb; 33(2):576-82.
-
Halle AA, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan HJ, Bourge RC, Kleiman NS, Miller LW, Aversano TR, et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol. 1995 Jul; 26(1):120-8.
-
Pearson T, Rapaport E, Criqui M, Furberg C, Fuster V, Hiratzka L, Little W, Ockene I, Williams G. Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group. Circulation. 1994 Dec; 90(6):3125-33.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
